-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VAO4SHc5d6cr0rH1ZRCTOROnWqDrAh1Vc9uCAX7SZ1cXpHFxNim4DFR47Sau1313
 dfwMCenCJhiSXfPPEH4pdA==

<SEC-DOCUMENT>0000912282-09-001690.txt : 20091117
<SEC-HEADER>0000912282-09-001690.hdr.sgml : 20091117
<ACCEPTANCE-DATETIME>20091117171418
ACCESSION NUMBER:		0000912282-09-001690
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20091116
FILED AS OF DATE:		20091117
DATE AS OF CHANGE:		20091117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		091191284

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>oncolytics6k_11162009.htm
<TEXT>
<html>
    <head>
        <title></title>
    </head>

    <body>
        <div style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid">
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 14pt" align="center">
            <b>SECURITIES AND EXCHANGE COMMISSION</b>
        </div>

        <div style="FONT-SIZE: 12pt" align="center">
            <b>Washington, D.C. 20549</b>
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 18pt" align="center">
            <b>Form&nbsp;6-K</b>
        </div>

        <div style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt" align="center">
            <b>Report of Foreign Private Issuer</b>
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 12pt" align="center">
            <b>Pursuant to Rule&nbsp;13a-16 or 15d-16<br>
            of the Securities Exchange Act of 1934</b>
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="center">
            <b>For the month of&nbsp;November&nbsp;2009</b>
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="center">
            <b>Commission File Number: 000-31062</b>
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="center">
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 24pt" align="center">
            <b><font style="BORDER-BOTTOM: #000000 1px solid">Oncolytics Biotech Inc.</font></b>
        </div>

        <div style="FONT-SIZE: 10pt" align="center">
            <i>(Translation of registrant&rsquo;s name into English)</i>
        </div>

        <div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="center">
            <b>Suite&nbsp;210, 1167 Kensington Crescent NW<br>
            Calgary, Alberta, Canada T2N 1X7</b>
        </div>

        <div style="FONT-SIZE: 10pt" align="center">
            <div style="MARGIN-TOP: 1px">
                <font style="BORDER-TOP: #000000 1px solid"><i>(Address of principal executive offices)</i></font>
            </div>
        </div>

        <div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left">
            Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
        </div>

        <div align="center">
            <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
                <!-- Begin Table Head -->

                <tr valign="bottom">
                    <td width="30%">&nbsp;</td>

                    <td width="5%">&nbsp;</td>

                    <td width="30%">&nbsp;</td>

                    <td width="5%">&nbsp;</td>

                    <td width="30%">&nbsp;</td>
                </tr>
                <!-- End Table Head --><!-- Begin Table Body -->

                <tr valign="bottom">
                    <td valign="top" align="center">&nbsp;</td>

                    <td>&nbsp;</td>

                    <td valign="top" align="center">Form&nbsp;20-F <font face="Wingdings">x</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F <font face="Wingdings">o</font> </td>

                    <td>&nbsp;</td>

                    <td valign="top" align="center">&nbsp;</td>
                </tr>
                <!-- End Table Body -->
            </table>
        </div>

        <div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left">
            Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(1): <font face="Wingdings">o</font>
        </div>

        <div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left">
            <b>Note:</b> Regulation&nbsp;S-T Rule&nbsp;101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
        </div>

        <div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left">
            Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(7): <font face="Wingdings">o</font>
        </div>

        <div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left">
            <b>Note:</b> Regulation&nbsp;S-T Rule&nbsp;101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s securities are
            traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
        </div>

        <div style="MARGIN-TOP: 10pt; FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 1pt solid">
        </div>

        <div style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: black 2pt solid">
        </div>

        <p style="FONT-SIZE: 10pt" align="center"><!-- Folio -->&nbsp;<!-- /Folio --></p>
        <!-- PAGEBREAK -->

        <p></p>

        <div style="FONT-FAMILY: 'Times New Roman',Times,serif">
            <!-- link1 "SIGNATURES" -->

            <div title="EE+ Page Break" style="FONT-SIZE: 1pt; PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 1px">
                <hr width="100%" noshade>
            </div>

            <div style="MARGIN-TOP: 18pt; FONT-SIZE: 10pt" align="center">
                <b>SIGNATURES</b>
            </div>

            <div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left">
                Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
            </div>

            <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
                <tr>
                    <td width="48%">&nbsp;</td>

                    <td width="1%">&nbsp;</td>

                    <td width="1%">&nbsp;</td>

                    <td width="35%">&nbsp;</td>

                    <td width="15%">&nbsp;</td>
                </tr>

                <tr>
                    <td valign="top" align="left">&nbsp;</td>

                    <td align="left" colspan="3"><b>Oncolytics Biotech Inc.</b><br>
                    (Registrant)<br>
                    &nbsp;</td>

                    <td>&nbsp;</td>
                </tr>

                <tr>
                    <td align="left">Date: November 17, 2009&nbsp;</td>

                    <td valign="top">By:&nbsp;&nbsp;</td>

                    <td style="BORDER-BOTTOM: #000000 1px solid" align="left" colspan="2">/s/ Doug Ball &nbsp;</td>

                    <td>&nbsp;</td>
                </tr>

                <tr>
                    <td align="left">&nbsp;</td>

                    <td>&nbsp;</td>

                    <td align="left" colspan="2">Doug Ball&nbsp;</td>

                    <td>&nbsp;</td>
                </tr>

                <tr>
                    <td align="left">&nbsp;</td>

                    <td>&nbsp;</td>

                    <td align="left" colspan="2">Chief Financial Officer&nbsp;</td>

                    <td>&nbsp;</td>
                </tr>
            </table>

            <p style="FONT-SIZE: 10pt" align="center"><!-- Folio -->&nbsp;<!-- /Folio --></p>
        </div>
        <!-- PAGEBREAK -->

        <p></p>
        <hr noshade>

        <p></p>

        <h5 style="PAGE-BREAK-BEFORE: always" align="left">&nbsp;</h5>
        <br>
        <!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->

        <p><font face="Times New Roman, Times, Serif" size="2">The following consent is incorporated by reference into the Registration Statement on Form F-10 (File No. 333-151513) of Oncolytics Biotech Inc. filed with the Securities and Exchange Commission on June 6, 2008, as amended on June 17, 2008, pursuant to the United States Securities Act of 1933, as amended. </font></p>

        <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
            <tr>
                <td width="48%">&nbsp;</td>

                <td width="1%">&nbsp;</td>

                <td width="1%">&nbsp;</td>

                <td width="35%">&nbsp;</td>

                <td width="15%">&nbsp;</td>
            </tr>
        </table>
        <!-- link1 "EXHIBIT INDEX" -->

        <div style="MARGIN-TOP: 18pt; FONT-SIZE: 10pt" align="center">
            <b>EXHIBIT INDEX</b>
        </div>

        <div align="center">
            <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
                <!-- Begin Table Head -->

                <tr valign="bottom">
                    <td width="3%">&nbsp;</td>

                    <td width="3%">&nbsp;</td>

                    <td width="94%">&nbsp;</td>
                </tr>

                <tr style="FONT-SIZE: 8pt" valign="bottom">
                    <td nowrap align="left"><b>Number</b></td>

                    <td>&nbsp;</td>

                    <td nowrap align="left"><b>Description</b></td>
                </tr>

                <tr style="FONT-SIZE: 6pt">
                    <td>&nbsp;</td>

                    <td>&nbsp;</td>

                    <td>
                    </td>
                </tr>
                <!-- End Table Head --><!-- Begin Table Body -->

                <tr valign="bottom">
                    <td valign="top">
                        <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px">
                            99.1
                        </div>
                    </td>

                    <td>&nbsp;</td>

                    <td valign="top" align="left">Consent of Independent Registered Public Accounting Firm</td>
                </tr>
            </table>
        </div>
        <br>

        <p style="PAGE-BREAK-BEFORE: always"></p>
        <br>
        <hr color="gray" noshade size="1">
        <br>
        <!-- MARKER FORMAT-SHEET="Para Right" FSL="Default" -->

        <p align="right"><font face="Times New Roman, Times, Serif" size="2"><b>EXHIBIT 99.1</b> </font></p>
        <br>
        <br>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 55.55pt; TEXT-ALIGN: center"><img src="img1.jpg"><br>
        </p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 55.55pt; TEXT-ALIGN: center">&nbsp;</p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 55.55pt; TEXT-ALIGN: center"><b><font size="2">Consent of Independent Registered Public Accounting Firm </font></b></p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 14.6pt; TEXT-ALIGN: justify"><font size="2">United States Securities and Exchange Commission </font></p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 18.5pt; TEXT-ALIGN: justify"><font size="2">We consent to the incorporation by reference in the previously filed registration statement on Form F-10 (SEC No. 333-151513) of Oncolytics Biotech Inc. of our report dated March 4, 2009, relating to the consolidated balance sheets of Oncolytics Biotech Inc. as at December 31, 2008 and 2007 and the consolidated statements of loss and comprehensive loss and cash flows for each of the years in the three
        year period ended December 31, 2008 and for the cumulative period from inception on April 2, 1998 filed with the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2008. </font></p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify"></p>

        <div align="left">
            <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="721" border="0">
                <tr>
                    <td valign="top" nowrap width="557">
                        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left"><br>
                        </p>

                        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify"><font size="2">Calgary, Canada</font></p>
                    </td>

                    <td valign="top" nowrap width="164"><img src="img2.jpg"></td>
                </tr>

                <tr>
                    <td valign="top" nowrap width="557">
                        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; TEXT-ALIGN: justify"><font size="2">November 17, 2009</font></p>
                    </td>

                    <td valign="top" nowrap width="164">
                        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; TEXT-ALIGN: justify"><font size="2">Chartered Accountants</font></p>
                    </td>
                </tr>
            </table>
        </div>

        <div align="left">
            &nbsp;
        </div>

        <div>
            &nbsp;
        </div>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left"><img src="img3.jpg"><br>
        </p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left">&nbsp;</p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left">&nbsp;</p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left">&nbsp;</p>

        <div title="EE+ Page Break" style="FONT-SIZE: 1pt; PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 1px">
            <hr width="100%" noshade>
        </div>
    </body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!^`C\#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`***2@!:*@EO((NK@GT7FJ<NJ.>(D"^[<UYV(S/"X?24]>RU9I&E.6
MR-(D`9-5Y;Z"+^/<?1>:RWFFG.&9F]A3TLKA^D9`]6XKQJF>5ZSY<+2;\]_P
M7^9NJ$8_&R:74Y&XC4*/4\FJKS22'+R,3]:N)I;'_62`>RBITTZ!.H+GW-<K
MP.:8MWJNR\W^B*]I2AL90+$X!8_0U,EK<R=$<#U)Q6PL:(,(@7Z"G5VT>'DO
MXM1OTT_S(EB>R,U--E/WYL>PYJPEA$OWB[_5JM45ZM'*\)2VC?UU,G5F^HU$
M5!A5`IU%%>BDHJR,@HHHI@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45&\T:<$Y/H.349FG?_
M`%4&!ZN<?I6$\13CIN^RU_(I1;+%0RW4$7WI!GT')J(VL\O^NN#C^Z@P*<EA
M;I_!N/JW-<LJN,J:4H*/G)_HK_F4E!;LKOJ3.=L$1/N>:C,5]<GY\@>YP*TU
M15&%4#Z"G5S2RVK7_P!XK-KLM$4JJC\,3-32C_RTD_!15A-/MTZJ6/\`M&K5
M%=%'*L'2^&"?KK^8I59OJ-5$0850OT%.HHKT4DE9&04444P"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHII=`,E@/J:`'4
M5"]W;H<-*N1NX_W1D_E3/M]OQABVXH!@?WNE`%FBJ$FJQI`\JQLP6-Y,'C[K
M8(IQOV^TB((,&<Q$Y_V-V:`+M%9!U.X:%7`12T4#],\N^#^E-EO+@[L2D?+<
M]/\`9(V_E0!LTUG51EF`QSR:Q&ED:XB!D8C[1!W/=.:K2G-D<\_Z*>O_`%UH
M`Z$W$(;:95W9(QGN!DC\JC-_;C&&)!V8PI_C.%K/1'>]?:I.+F7.!_TS%31:
M=*T<>]@F%@..IRG)%`$LFJ1(CL(W.U)']/N'!IXNY'F,:0DA90C'V*;L_KBG
MQV4"=5WGY_O<\,<D?G4]`$$8NW0&0I$2@R%&<-GG\,5,4!X.33J*32>C`0*%
MZ`#Z4M%%"26B`****8!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4TR(O5U'3J?7I6/&[M>*&=B!?2`9/;RSQ5>/_5)_UQM/
M_1AH`W&NX$!+2KP&)_X#][\J9]O@\SRP23O5.G=AD?I67+TE^EU_,4J_\?:_
M]=X?_1=`%UM5C$1D6-B!'OQT_BVT'46,YC$:\2O'G/\`=7=FLP_\>A_Z]C_Z
M,J?_`)?6_P"OF7_T6*`)AJ,[",_*-RV['`_OL0U0O>7#0.3*0?*N3QQRK@+^
M0J-/N0_]<[/_`-"--/\`Q[R?]<;OO_TT%`%HNYOD!=L?:T&,_P#3'-4X.;%.
M_P#HL7_HPU:/_'^O_7VG_HFJT'_'BG_7M%_Z,-`#I_\`7/\`[US_`.@BEB_Y
M9?[]K_*DG_US?[US_P"@BEB_Y9?[]K_*@".7_D'R\_\`+M/_`.C*MG_C_7_K
M]/\`Z)JLZ-)92(BEF-O.`!U)\RM!;.9KLR$!56Y,G)ZCRPO\Z`,T?\>J?]>]
MK_Z,-2LC2.512Q(NP`/7<*TH=-ACC17S(5C2,YX!V'(/YU;"JOW0!DYX%`&6
MFGS/*KMA`LD4G/4[4P1^=6HM-MT0*X,F$V?-T(SGI]:MT4`(`!T&,TM%%`!1
M110`5FZ_>-8Z3+*EY%:2$A4EE4E02?0`]LUI5SOBZZ:*WMX5NK"`NQ8B\7<&
M`]!@^M`&,GB'4XK"]NCKEI>>3$`BPPX*N2`"<J/>M;1=4U&\UYK2>8-%!9HT
MH"`9D8`_AUZ5SLCVUSIWV6XU72$9KA'?R%V`H,Y'"\G)K?\`!Q6ZN-6U)>5G
MN=J'_97I_,4`%[J>I77C`:/8W@MHDAW.WE*Y!QGO]16BM\-%58M7U/[1-.Q\
MK$&"0.V%S7-:3!8:QXEU>[OI`(U?;&?.*'J1V(["G:LS6&NPKIL:RII5FTX6
M1RV=QY.>IZYH`ZD:_I9L7O?M:B!'V.Q!&UO0C&15N:Z@@M_M$D@$7&&'.<G`
M_G7*P:=8WUAI]JCO-'J4CW5PY."Q"G/3IAB/RJ"QEO+.]A\,7V66&=9HIB>&
MA7+<_D*`.I?6+)+@P>8[,KB-F2-F56/0$@8!J"3Q)I<<_D/+()>?D\A\D#N.
M.16/:)?Z!X@AM8YTN[#4I6D4'[R$\DU:M#]K\=WLN25L[98A[%N:`-FZU"VL
M[+[9.Y2+`P=IR<]!CKGVI;._AO?,$8='B;;(DBE64XR,CZ&L'Q'(=8GFT*V*
MI-#$+CS';'S#[H7_`![4[PIJ;:C;JL<:H\1/VQG.6>3H,?EG/X"@!ECKE[#X
MKO-+U*9#`B,\3%0O`YR3]/Y5;MM<&]KR\G\JWN#ML[<)F211_'@#//IZ5D:_
M;0ZAX[TZUV9_=@S<XW+R<'\/YU>T./S_`!5K%Q<`>=;LL,*G^"/V'O@4`;-K
MJ]E>22Q12D2PC,D<BE&4>N#4MG?6VH6PN;642Q$D!P"`<=>M<EJUP;G7=0U"
MT!:&PL'BDD7HSD'C/?&?TK3TV1--\#0,CKN-O\F#]YVZ`>^30!JQZQ8236\*
MW*^9<J6B4@C>!UQ5AKB);E+<O^]=2RK[#&3^HKDKG0)-06=;9REUID<,5LX.
M/G5=S#\<BJ5UK%YJ>C:A?B-X9[>W2UEQP5)8ES[<`4`=:=>T_=((Y'F6(XD>
M&)G5/J0,5?AFCN(4FB;='(H96'<&L8WUIX>\+VTT,0DB"HJ(C`;RWO\`K6TG
MW%^7;QT]*`'4444`%%%%`!1110!6O[Q=/L9;IT+K&,E1U/.*K1ZY:F%7F#QL
M4#[0I?`)P.5XY-3ZF;8:=+]K5FAP`RKG)YX`QWSBJ$$FEK*+65)H9I%5MEPS
M%B%9B.<GH030!/+X@L(X7D1WEV*K%40DX8@#M[U)<ZM#;7UM:.K9N`2&X`'U
MS6;/)X;A@:5I-X\E@%5V)V@\X'8Y%3W;:#<RK-<3(7BV#.]@1SE<CN<_SH`L
MW>LP65T8)T=3@,&QD%.[?@>,=>1ZTO\`;FG>49/M'RKP?E/!P3@\=<`_E5>^
MOM%EC,L\R2\&'",23DC(&/H.:9-8:+%?0V4D+"66-B/F;:>#G<<]2"W)YZT`
M78M8L9I8XDE)>0X`V,,'G@\<'@]?2E.IQK&7\ML"Y%O^.[;GZ50QHCWUO=QW
M:HXD8@!SB0\]?IN/YTIBT*Y$DOV@E9G#MMG<#=NX(&>#F@"P^MQ)K`TTPN6W
M!=X8=2,CCKCWK3K'M+_1H)U6WGWO.I)<EFR$`ZD^QJPVN:8$#"\C8%"X"\D@
M9_P/Y4`:%%5+74[.]95@F#.4$FWN`>F:MT`%%%%`!1110`4444`%%%%`!111
M0`4444`8</\`Q^CG_E_E[_\`3,U#%_JD_P"N-K_Z,-31?\?J_P#7_+_Z+-0Q
M_P"J0?\`3&U_]&&@"67[LOTNOYBE3_C['_7>'_T722_=E^EU_,4J?\?8_P"N
M\/\`Z+H`A/\`QZG_`*]C_P"C*G'_`!^M_P!?,O?_`*9BH&_X]#_U['_T94X_
MX_6_Z^9?_18H`C3[D/\`USL__0C2'_CWD_ZXW??_`*:"E3[D/_7.S_\`0C4T
M=C/+$R[=NY+E,MV+/D?AB@`/_'^O_7VG_HFJUN,V*`9)^RQ=.?\`EH:UUL$\
M[S78D^8)`!Q@A-M3Q010(J1(%51@8["@#--A/-,QP$7?/R?1@`#5F'38XU7>
MQ<@1^PR@P#5VB@!J1I&NU%"@9X`_&G444`%%%%`!1110`4444`%%%%`!5:ZT
MZROF5KJUBG*C"F1`<59HH`SO[`T?_H&6O_?H5;MK2WLXO*MH4ACSG:BX&:FH
MH`SFT#1V)+:9:DGDYB%6EL;5)7E6WC#R($=@HRRCC!]JGHH`KP6%I:[/(MXX
MM@(7:N-H/7%.EM+>>022PH[A2H9ER0#U'XU-10!4M-+L;%BUK;)&Q&,CD@>G
ML*FBM8()998H41YCF1E&"Q]ZEHH`JW&F6-W.D]Q:0RRIPKN@)%.AL;2VF>:"
MVBBDDX=D4`M]:L44`0?8[;[7]K\B/[1C;YNWYL>F:CN=+L;R42SVR/(!MW\@
MX],BK=%`$4-K;P0?9X88TBQC8J@#\JK6^C:;:2B6"SBC8'(('0^P[5>HH`9'
M#'$7,:*I=MS8'4^IIJVT">;MA0><<R84?.??UJ6B@#/CT+2HY`Z6,(*G(&W(
M!]0.@K0HHH`****`"BBB@`HHHH`K:@D$EC(EP&,9QG9][.1C'OG%4#:::\>+
MBXEW[5W>=+\_5L9_[Z-:5W&DMLZR-M7J3@'&#GH:IE;-2H>X^9L/G&!C:0.V
M!QF@"O%INDVX>U65F-R#$?GR3GD_0T^WT_3OM\S1F5IXW5WW'.6'?\:=`EE`
M\;)<OP0`I7'08Y&.,Y')]JL"V@LKA[MYF7><$'&"2>/J?3VH`SH]+T9D$<<T
MB`MD8DQD'!V^XX'%6KC3]+N+X7$S@W#%=A\SD8[#V.?UI9HK%'D1IB"&_>(H
MR3N)8#@>QZ4?9+5`K/<2/YP4!L<8^7'(''W10!`=/TZ*V,JS7$T<*E&"2EOD
M_N'_`&138]*TM@"9YE=?FD#RX8]QN^F*M0PPPVDZ3W2LDQV`@C@8"@?6G2V=
MK)*T,LQ)QO"'`P">?P/2@"NVFZ4`R_:"N$(;$V/EVA3G_OD?B*D@T&QBB`3S
M&4\Y+]?O?_%FG)IUI"^?/R0H)W$9X[_I5_S(]N[>N,9SF@"I;Z5!;72W"/*S
MK$(AN;(P/7U/%7JB>YA39E\[_N[1G/OQ39+RWB<I)*JL,\'V`)_0B@">BBB@
M`HHHH`****`"BBB@`HHHH`****`,.+_C]'/_`"_R_P#HLU#%_JD_ZXVO_HPU
M-#G[:/\`K_E_]%FDMK::6)-D9P8;<Y/`^5R3^E`!-]V7Z77\Q2K_`,?:_P#7
M>'_T75Y=.#%O,?@F7A?1S5F.WBC)*H,G&2>IP,#]*`,B.SGFM@%0C=`5!;CG
MS,_RK033U$S2NY.96D`'^TH7%7**`(XH(H5"QH!A0H]<#H*DHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@".<@0.3((QM/S'M5`V<,EN
M&:Z!A*J'(&,E>`?;_P"M5ZXB,T)0-M.0P)&1D'(_E5*?3KBYE$DDZ#Y<85>E
M`#CINYW=K@EI>)#M'S`8X'ITJ6:S^U1H)I6#H/O1G`S]*III<[$AG1%#@C`Y
M;'\7UJ=;&2&2'R2N$4[L\!F[$_F?TH`1K**&X+I=M'*1O`<AAQG)Q_P*GK:*
MX@\NX#10KM"D9!([]>M%QI[SW1G%P5.W:%VC&,$'W[_H*@?1W?/[Y0-Q.`N-
MV2>OOSQ0`]M+A#(JS!2`,J5'(7;R/?@<T^YLX!))=SSLJD$-D_+M(QC^M(VF
M?*/+*!OGRS+DG<<]?TJ>*U,>G_92^3L*[OKF@"@+:QW;FO`V4#'=WQU/ISZ4
M2VEJ\._[;MB9SC`_BYX_7I5FXL9KAG5I4\LIM08.4.,$_6I);%3;^7'@MNW%
MI"2<XQG.<YQ0!6D2T,"P?:D0Q')8#D$G/!SP>:D;3X[J07/GEMVT@@#'!_J.
M/PI$TZ51(IE5PQ#*Y+!@PQSU_E5RV@%M;I"I+!1U/4GN:`'H&"`,VYNYQC-.
MHHH`****`"BBB@`HHHH`****`"BBB@"%+6&-BRQC)<R9//S$8)J:BB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`(Y
MV=(7:/;N49&[I5--3+%8_+)?<%8@87/?'YU:NY?(MF?:&Z#!Z')Q_6JC7EG&
M9!-$H=0N_:N1Z#]2!^-`$EUJ*VTD494;GP6!/0'^9S43:C,L#2&-#L57(&3\
MI_P]:GNKN*UM#*\7W3A(VP,D=,?E5=)(9"`ME%M8LT9]6&,Y`'^<4`3W%U-'
M-LAC6;"[B@SD<'!ST[5735)6+?NUQ%]\D$;AD#Y0?K3VFB>".^6U0RN.A/S'
MM@<<FHQ=QF=(!9IY@;]T#QMY/7CCIGC-`%AM0'V\VB!20C$DG'S#!Q^M1R:F
M\<?F&)2JHC.,\DMZ?2G37\!2WW1AFGP-I(&U20#_`)[U";F&%U7[)'N0[(R@
M)`&,GD#MW^M`%VUG>;S%D"AD(R5Z'(!_K5BJ5E.C2O"D*PH,E``1O&?O#C&.
MG2KM`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!%</%'"7F^
MX"#^.>/UQ50?V9-OEVJVX%F)!Z<$G'XBKLT23QF.094U!]@@+LS`D,H4C)Z#
M/Y]?Y4`1O<V21M'(I"G)*NA/)SQ]3SQ43-I^R258<'A6R"G&<?IM[>E6CI]N
MWWU9_P#><G/O]>:5K*!CDIGKD9X.<Y_F:`(=MC*T$)C96`)C'S*1ZU8>T@D#
MAXP=Y!8Y.>.G--2RACE$H#%P.I8FK%`$9MX614,2E4QM&.F.E0KIUHL?EB+Y
M`<@;CQ].>*M44`11VT,4AD1`&(QG/;T'I4M%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"``G`-`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V1W2)"\CJ
MB*,EF.`!7F.O^-+S5?%K:+ITM\VC0H#-=:)%Y\TSG'R;QQ&!G!(YX]^,6Y\0
M-J?CO4]+\46\U_+!<&+2]+$JQ6KC+?-(2<'Y0#DY[\=J]`M-/\7);(EO/H.D
MPKC9;V]J\H4>A.Y1^0H`J>$M#T=-6.H0>&M6L;F-"$O-1F):7/!R#(3GZBNU
MKA%\>76C>)(M'\0RZ7-'+&SF\L)"%M\?\]58G;GMS6-XO\;Z_=Z4=7\/*;31
M+>>-!<R#;+?$L!B,$<)[GK0!ZI17(WOC:2X=K'P[:1WM]$FZZDEEVVMEQD^9
M(."1Z+GI7,Q_%C6+CPG)J-EX>-W<69(O+A<K:H`V`5R=S9&#@=.]`'JE%>8Z
M]\5@#80Z;OL+2\R'UB[LY&B4@9(1."W.!D\<TV?Q@^L>&M*D&O7<.L3P$MIV
MCQI++,W9FR#Y8Q@\XQGVH`[S7/$-CH$=M]J\V2:[F$-O!"NZ25CZ#V[GM6G7
MCW@'PKJ7BJ6?7_%&L:G]HL)WMK?9<[6C*\.=PZ>G'O7K&GVT5I9)'!<2W$?5
M9)IC*6S_`+1)S0!:HKRKQ!\2O&7A2=VUGPI;+:LY2&:.8E&/./FYSP.F`:Z7
MX?CQ&=,\_6[=(S=DW#2/<F221GP1A0,(@7`"Y-`'5W,XM;66X:.201(7*1KN
M9L#.`.Y]JX>^^*]G#-;6EGH&KSWEW)Y<,4UOY`<_5OKZ5WM>9WVOVME\5;RY
MUNVOF^P6R0Z5#%;/+YA<9D9=HQGG'-`'?ZKJMKHNDW&IWS^7!;1EW/?Z#U)/
M`K'\%7>O:K8S:SK1$$=\P>SL@@!MXN<9/4EN#S7F7BSQQJ>J:^T6J^'[D:/I
M.VXEL58$LY_U?GL,A1DCY:W]/\7>,!J.GS9M]8:]0SSZ181KFS@(^0F4GAB3
MT/7%`'J=%>?:;\2I)M9U4ZU;P:+INF*(W2=]]P\S<@`*<'@'@`]N:FT+XG6F
MJ+J6H72)9Z;!,MO:(<M<W$F.1Y8R?3``_D:`.[HKSVY^).IZ;X@@L=2\,7$,
M5_"6L(8W5[F1@<`.H.%S^G?OA^B_%"U6/4T\6&UT:[L+@Q_9UE\QF&.P&2QS
MQD<4`=_17CFM_%3Q'J.J6=KX8M+>!+N0);I/M>>8'HQ7.$7Z\]Z]<CE:&VA^
MVRPK,557(.U2_?&??I0`Z2X@BECBDFC224D1HS`%\=<#O3IIHK>)I9I$BC49
M9W8``>Y->=IK.F:I\9)C>7UO"FAVAAMTE<+OF;_6,,^@X-6?B7J]E<VFC:$;
MZ".#6;Q/.E:0!/(4AF.>F"=HH`[F>Y@M;=[FXFCAAC7<\DC!54>I)Z5GVOBG
MP]?7"6]IKFG3S/\`<CCND9F^@!YHU*^L9-#OFABMM32WA+/:B1"K`#.TYX'3
MO7EOA/PQK'C;0+8ZG;6]GILEZUZ+M"#.X!P(XP/]6O7GVX%`'6>$O`B6^GZA
M:^*=+L=0N9KMY?MCJLAN`W?D94]>/>M1?AQX14\:,F"<[?-DV_\`?.[%=/10
M!F)X:T)+(V2Z-8BV+!S%]G3:6'0D8Y/O4FJ:'IFM:;_9VHV<<]ID$1'(`QTQ
MC&,5?HH`H0Z)I=OI#:1#801V#(8VMU3"LI&"".^:LVUI;6=JEK;01PP1KM6)
M%`4#TQ4U%`%'5-&TW6K06FIV4-U`&#!)5R`1W'I3M/TC3=)0IIVGVUFK=1!$
MJ9^N!S5RB@#FQX!T`7,TODW)BGE,TEK]JD\AG)R28\[3S[8KH8XXX8EBB18X
MT`5548"@=`!3Z*`.>\4^"M+\7R6)U1[@Q63LXACDVK)G'WN/;MCO6^JJB!%`
M55&`!T`IU%`",P52S$``9)/:O/=<\1ZGKVFZA=Z=<OI'AVSC8R:F%_?W9':$
M=E)XW=^U:/C^YENI='\+Q2-$NN7)CN)$.#Y"#<X!]QQ^=5?&L2:AJGASP7:H
M$MKB83W,:\*+>$9"_0D8_"@"U\.O#$.E^!(+>]@66744,]V)1N+[^@;/7"X'
MYUTFE:+IFAVQMM+L8+.(G)6)`NX^I]?QJZ``,`8%+0!C+X1\/KKDFM_V5;G4
M)#N:=ER<^H!X!]QS3K/PKH5AK,^L6VF0QW]P29)\$L2>I&>F?:M>B@#/_L/3
MCKW]N-;AK_R!`LK$G:F2<`=!UZUG^*++PO%I5U?:_I]H\!`\QVA!D<]@"/F+
M$X`QS705Q.IW-OJ7Q!9+^>./3?#=H+R19#\OGOG:Q_W5!(]S0!QNC:#)XG\9
M)8QZ:_A.RTNW^TPQVFU;I_,X!=^2&(SUY'ZUZ7IG@S0M+N!=1V9N+O.?M-W(
MT\N?7<Y.#],51\%6TUY-J7BFZB:&369%:")AADMT&V//N1EOQKJZ`,)?!/AA
M1)NT*RE,LS3N9HA(2[=3ELG\.E27?A#PY?S0RW>C6DS00^1$'C!5(_[H7H.I
M[<5LT4`9-IX8T73],N=-L=.AM+:Z0I,L`VEP00<D<]"?I5S3=.MM)TVWTZS0
MI;VT8CC4G)`'O5JB@`HHHH`****`"BBB@`HHHH`****`"BBB@#E/'7A^^U./
M3]7T?:=4T>?SX(W;:LJG&Y">V0.M9/@JZ;Q9XSU7Q5)`\$5M"EA;12$%D(^:
M3.#C[W?THHH`]!HHHH`****`"N?U/P3H6KZVFKWMJ\EP%5742$1RA3E=Z]&P
8<=?0444`;X&!@4M%%`!1110`4444`?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img3.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"``,`ND#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`JC'=7!U"6-H7$`&(W*\$CK
M[\Y_2KU%`&4^H7\:J3;*V['*J?DZ=?S/Y4DM_J"H[+;KP#@!23G@?CU_2M:B
M@#(&I7W*K;!B$)#%2`YQV^AJ>ZFO(94*@.HCRP53@MN'],UH44`9;7M^C_ZA
M&4`=$;)X!./SQ^%/GN[O[288D`4.H)*DD+D<^G.3^5:-%`&8;F\%[*B\CS%1
M%*G`!QD]/ZTQM0O]O_'NH)Z85B?XAT_`'\:UJ*`,J:]NXH[)]K.'`,VQ.3TZ
M#\_Y]JENI[R&Y(0+Y(`.XJ3C/&#CL.M:%%`&5_:-Z[+&ML%<GDLK$*.,'\<G
M\J<E_<RK,!$JR+&65,'</3/KFM.FA%#%@H#'J<<F@#*^WW*-F,/)&`0))(S@
MGUP!^%(-3O4C?=;EF!)"[#\O4[3[X`P16Q10!1BNY`L7GY!=6_@/7/`_*H6O
M;]4W>0NW'0*=W8?U_2M2B@#(CU"_56#P!R"Y^Z1P"<#\L'\:OV<DDL&Z4@MN
D(R`0",\=:L44`%%%%`!1110`4444`%%%%`!1110`4444`?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
